Cure My Disease

Don't miss your cure!

 Log in / Sign up

Needle vs light: which zaps shoulder pain best?

NCT ID NCT07695792

Recruiting now Symptom relief Sponsor: Universidad Pontificia de Salamanca Source: ClinicalTrials.gov ↗

First seen Jul 10, 2026 · Last updated Jul 17, 2026 · Updated 1 time

Summary

This study tests whether two types of percutaneous electrolysis (simple or multifilar) or laser therapy better relieve pain and improve shoulder movement in people with supraspinatus tendinopathy, a common cause of shoulder pain. Participants receive one treatment session and are evaluated before, right after, 24 hours, and one week later. The goal is to find which technique offers faster and longer-lasting relief.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
percutaneous electrolysis (simple or multifilar) and laser therapy
What this could lead to
If one method proves superior, it could offer a more effective, non-surgical option for treating chronic shoulder tendon pain.
What could go wrong
This is a small, early-stage trial with only 60 participants, so results may not apply broadly. The invasive electrolysis procedure carries minor risks like pain or infection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TENDINOPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

disease of the tendon Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TENDINOPATHY

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Universidad Pontificia de Salamanca

    RECRUITING

    Salamanca, 37002, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.